Dipeptidyl peptidase-IV inhibitory action of Calebin A: An in silico and in vitro analysis

Background: Dipeptidyl peptidase-IV (DPP-IV) inhibitors, the enhancers of incretin are used for the treatment of diabetes. The non-glycaemic actions of these drugs (under developmental stage) also proved that repurposing of these molecules may be advantageous for other few complicated disorders like...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nehru Sai Suresh Chalichem, Srikanth Jupudi, Venkata Ramesh Yasam, Duraiswamy Basavan
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/fd9ef96a030a49378f8d1dcf67396cdb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!